You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LABA/LAMA

Showing 1 - 25 of 305
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pathways of Asthamics Treated With ICS/LABA/LAMA Therapy

Not yet recruiting
  • Asthma
  • (no location specified)
Oct 24, 2023

A Multicentre, Prospective, Non-interventional Trial Monitoring

Not yet recruiting
  • ASTHMA
  • Non-interventional
  • (no location specified)
Feb 6, 2023

Copd Trial in Assiut (SABA SAMA ICS Vs LABA LAMA ICs)

Not yet recruiting
  • Copd
  • SABA SAMA ICS Vs LABA LAMA ICs
  • Assiut, Egypt
    Nermen Mohammed Abuelkassem
Feb 28, 2023

Pathways of Asthma Patients Treated WithExtrafine ICS/LABA/LAMA

Recruiting
  • Asthma
  • Non-interventional
  • Durham, County Durham, United Kingdom
    The Haven Surgery, The Haven, Burnhope,
Jul 20, 2022

Copd Trial in Dallas (TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation)

Not yet recruiting
  • Copd
  • TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation
  • Dallas, Texas
    Baylor Scott & White Health Research Institute
Mar 22, 2022

ivenesS of BDP/FF/G Fixed triPle cOmbiNation on Symptom scorEs

Not yet recruiting
  • COPD
    • Budapest, Hungary
      National Korányi Institute of Pulmonology
    Feb 15, 2023

    COPD Trial in Llanelli (Any LABA/LAMA)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Any LABA/LAMA
    • Llanelli, Carmarthenshire, United Kingdom
      Prince Philip Hospital
    Aug 2, 2022

    Fixed LAMA/LABA/ICS Triple Therapy

    Completed
    • COPD
    • Non-interventional
    • Liverpool, United Kingdom
      Liverpool Heart and Chest Foundation Trust
    Jul 20, 2022

    Pulmonary Disease, Chronic Obstructive Trial in Brussels (LABA, LAMA)

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Brussels, Belgium
      Erasme University Hospital
    Jun 23, 2023

    Fixed-dose Dual Bronchodilator in Heart Insufficiency and COPD

    Withdrawn
    • COPD
    • Spiolto® Respimat® (Tiotropium / Olodaterol)
    • Aachen, North Rhine Westphalia, Germany
      Clinic of Cardiology, Angiology, Pneumology and Intensive Medici
    Oct 25, 2022

    South Korea Using Medical Records to Look at Different

    Completed
    Has Results
    • Pulmonary Disease, Chronic Obstructive
    • Long-acting Muscarinic Antagonists (LAMA)
    • Inhaled corticosteroid (ICS)/Long-acting Beta Agonists (LABA)
    • Seoul, Korea, Republic of
      Konkuk University Medical Center
    Feb 8, 2022

    COPD Trial in Mexico City (Fluticasone Furoate/Vilanterol 100/25 mcgs, Umeclidinium/Vilanterol 62.5/25 mcgs)

    Completed
    • COPD
    • Fluticasone Furoate/Vilanterol 100/25 mcgs
    • Umeclidinium/Vilanterol 62.5/25 mcgs
    • Mexico City, Tlalpan, Mexico
      National Institute of Respiratory Diseases 'Ismael Cosío Villega
    Apr 18, 2022

    Quality of Life (TRISNOOZE)

    Terminated
    • Chronic Obstructive Pulmonary Disease
    • Trimbow
    • Ghent, East Flanders, Belgium
    • +10 more
    Nov 25, 2021

    COPD, COPD Exacerbation Trial in Winston-Salem (Nebulizers, Dry Powder Inhaler, Brovana)

    Terminated
    Has Results
    • COPD
    • COPD Exacerbation
    • Nebulizers
    • +6 more
    • Winston-Salem, North Carolina
      Wake Forest Baptist Health
    Jun 10, 2021

    Bronchiectasis Adult Trial (LABA/LAMA or Placebo inhalation)

    Not yet recruiting
    • Bronchiectasis Adult
    • LABA/LAMA or Placebo inhalation
    • (no location specified)
    Aug 11, 2020

    Effectiveness of Triple Therapy in COPD

    Completed
    Has Results
    • Pulmonary Disease, Chronic Obstructive
    • Long-acting beta2-agonist-long-acting muscarinic antagonists-inhaled corticosteroids(LABA-LAMA-ICS)
    • Long-acting beta2-agonist-inhaled corticosteroids-long-acting muscarinic antagonists (LABA-LAMA)
    • London, United Kingdom
      Clinical Practice Research Datalink
    Nov 29, 2019

    A Retrospective rEal-life daTa Study to Assess exaceRbations and

    Completed
    • COPD
    • COPD Exacerbation
      • Thessaloniki, Greece
        Papanikolaou Hospital of Thessaloniki
      Sep 7, 2022

      COPD Trial in Chongqing (Glucocorticoids, Antibiotics, Inhaled corticosteroid (ICS))

      Completed
      • Chronic Obstructive Pulmonary Disease
      • Chongqing, Chongqing, China
        Daping Hospital
      Oct 22, 2020

      Tiotropium and Olodaterol in Comparison to Triple Therapy

      Completed
      Has Results
      • Pulmonary Disease, Chronic Obstructive
      • Tiotropium and Olodaterol (Tio+Olo)
      • Long-acting beta2-agonist and Inhaled corticosteroids (LABA and ICS)
      • Andover, Massachusetts
        HealthCore, Inc.
      Nov 12, 2021

      Chronic Obstructive Pulmonary Disease Dual Therapy Burden of

      Completed
      Has Results
      • Pulmonary Disease, Chronic Obstructive
      • UMEC/VI
      • +5 more
      • Durham, North Carolina
        GSK Investigational Site
      Jul 20, 2020

      Pulmonary Disease, Chronic Obstructive Trial in Italy (Bronchodilator Agents)

      Terminated
      • Pulmonary Disease, Chronic Obstructive
      • Bronchodilator Agents
      • Bari, BA, Italy
      • +38 more
      Dec 23, 2022

      Treatment of Obstructive Lung Diseases

      Unknown status
      • Chronic Obstructive Pulmonary Disease
      • +2 more
      • LABA + LAMA
      • +4 more
      • Leuven, Vlaanderen, Belgium
        UZ Gasthuisberg
      Apr 7, 2020

      Chronic Obstructive Pulmonary Disease (COPD) Participants

      Recruiting
      • Pulmonary Disease, Chronic Obstructive
      • prospective observational cohort study
      • Hannover, Niedersachsen, Germany
        GSK Investigational Site
      Jun 20, 2022

      COPD (COPD) Trial in Worldwide (Placebo, Tozorakimab)

      Not yet recruiting
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Sheffield, Alabama
      • +31 more
      Sep 11, 2023

      Spiolto® Respimat® Versus Triple Combination Therapy in Everyday

      Completed
      • Pulmonary Disease, Chronic Obstructive
      • Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist
      • Triple combination of Free or fixed Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist + inhalative corticosteroids
      • Bad Sachsa, Germany
      • +74 more
      Nov 10, 2021